Month: January 2025

Lassila & Tikanoja plc will publish Financial Statements release for 2024 on 13 February 2025

Written by Customer Service on January 24, 2025. Posted in Public Companies.

Lassila & Tikanoja plc Investor News 24 January 2025 3.00 pm Lassila & Tikanoja plc will publish Financial Statements release for 2024 on 13 February 2025 Lassila & Tikanoja plc will publish Financial Statements release for 2024 on Thursday 13 February 2025 at 8.00 am. After publication, the release will be available on the company’s website at www.lt.fi/en. Lassila & Tikanoja will host a conference call and webcast for analysts, institutional investors and media on 13 February 2025 at 10.30 am Finnish time. The presentation material will be published on the company’s website. The English language briefing will be hosted by CEO Eero Hautaniemi and CFO Joni Sorsanen. Conference call You can access the teleconference by registering on the link below. After the registration you will be provided phone numbers...

Carbon Revolution Secures Further Release of $5 Million from OIC and further $0.4 Million Reserve Release from Existing Lenders

Written by Customer Service on January 24, 2025. Posted in Public Companies.

GEELONG, Australia, Jan. 24, 2025 (GLOBE NEWSWIRE) — Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that Orion Infrastructure Capital (“OIC”) has released an incremental US$5 million of the US$25 million facility announced on December 23, 2024. As a result of this most recent release, $10 million of this US$25 million facility has now been released. Concurrent with this US$5 million tranche, lenders under the US$60 million PIUS loan entered into in May 2023 (“Existing Noteholders”) have also released a further US$400,000 of existing loan reserves, taking reserves released to US$800,000 of the up to US$2 million agreed to be released. In connection with this funding tranche,...

Desktop Metal Dismisses Markforged from Previously Filed Complaint

Written by Customer Service on January 24, 2025. Posted in Public Companies.

Exhibit 99.1 WALTHAM, Mass., Jan. 24, 2025 (GLOBE NEWSWIRE) — Markforged Holding Corporation (“Markforged”) (NYSE: MKFG), the company strengthening manufacturing resiliency by enabling industrial production at the point of need, announced today that Desktop Metal, Inc. (“Desktop Metal”) has voluntarily dismissed Markforged without prejudice from its previously filed complaint against Nano Dimension Ltd. (“Nano”) and Markforged brought in connection with Markforged’s pending merger with Nano (the “Action”). As previously announced, on September 25, 2024, Markforged entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Nano pursuant to which Nano will, subject to the terms and conditions in the Merger Agreement, acquire all outstanding shares of Markforged (the “Merger”), with Markforged surviving the Merger...

Foresight: Eye-Net Partners with Industry Leaders to Transform Urban Mobility and Road Safety Across Europe

Written by Customer Service on January 24, 2025. Posted in Public Companies.

Ness Ziona, Israel, Jan. 24, 2025 (GLOBE NEWSWIRE) — Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX), an innovator 3D perception systems, announced that its wholly owned subsidiary, Eye-Net Mobile Ltd. (“Eye-Net” or “Eye-Net Mobile”), entered into a groundbreaking collaboration with Software République, a consortium of global industry leaders, to integrate and test Eye-Net’s vehicle-to-everything (“V2X”) collision avoidance solution. This collaboration represents a significant step toward redefining urban mobility and road safety across Europe. Eye-Net offers a collision-avoidance solution designed to protect road users within a connected ecosystem that provides real-time alerts and information to all road users to create a safer and more predictable road environment. The collaboration, originally announced on November...

Sword Health Acquires Surgery Hero to Accelerate Global Growth and Expand its Presence in the UK

Written by Customer Service on January 24, 2025. Posted in Mergers And Acquisitions.

As part of this acquisition, Sword Health will collaborate with 18 NHS trusts serving 10 million people to implement its AI Care model, enhancing care delivery and management while significantly reducing costs LONDON and NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) — Sword Health, a global leader in AI Care, making world-class, life-changing care accessible anytime, anywhere, today announced its acquisition of Surgery Hero, a UK-based innovator in prehabilitation digital health. This acquisition bolsters Sword’s investment in the UK, where the National Health Service (NHS) faces the challenge of long musculoskeletal care waitlists and high healthcare costs. It also underscores the company’s commitment to improving patient outcomes and expanding its impact while expanding their global footprint. Surgery Hero’s expertise in prehabilitation...

X4 Pharmaceuticals Announces EMA Validation of Marketing Authorization Application (MAA) for Mavorixafor for the Treatment of WHIM Syndrome

Written by Customer Service on January 24, 2025. Posted in Public Companies.

Submission supported by positive results from global, Phase 3 4WHIM clinical trial; U.S. regulatory approval in WHIM syndrome granted in 2024 Decision on MAA expected in 1H 2026 BOSTON, Jan. 24, 2025 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that its Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia, infections and myelokathexis), a rare primary immunodeficiency, has been validated for review and is now under evaluation with the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP). The EMA previously granted orphan designation to mavorixafor in WHIM syndrome. In April 2024, mavorixafor received U.S. Food and...

Appendix 4C – Q2 FY25 Quarterly Cash Flow Report

Written by Customer Service on January 24, 2025. Posted in Public Companies.

HighlightsTopline data for ATH434-201 randomized, double-blind Phase 2 clinical trial on track for expected release by early February 2025 ATH434-201 trial in early-stage MSA completed in November 2024 Positive interim data presented at MDS from the ATH434-202 Phase 2 trial in advanced MSA Multiple data presentations and publications showing the potential for ATH434 to modify disease progression in neurodegenerative conditions Cash balance on 31 December 2024 of A$4.54 mMELBOURNE, Australia and SAN FRANCISCO, Jan. 24, 2025 (GLOBE NEWSWIRE) — Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today released its Appendix 4C Quarterly Cash Flow Report and update on company activities for the quarter...

Abaxx Announces Closing of Final Tranche of C$2,756,000 Private Placement

Written by Customer Service on January 24, 2025. Posted in Public Companies.

/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ TORONTO, Jan. 24, 2025 (GLOBE NEWSWIRE) — Abaxx Technologies Inc. (CBOE CA:ABXX) (“Abaxx” or the “Company”), a financial software and market infrastructure company, majority shareholder of Abaxx Singapore Pte. Ltd., the owner of Abaxx Commodity Exchange and Clearinghouse (individually, “Abaxx Exchange” and “Abaxx Clearing”), and producer of the SmarterMarkets™ Podcast, is pleased to announce it has today closed its final tranche (the “Final Tranche”) of a non-brokered private placement financing (the “Financing”). The Final Tranche consisted of the issuance of 50,000 common shares (the “Shares”) of the Company at a price of C$13.00 per Share for aggregate gross proceeds of C$650,000. The Financing, which consisted of the Final...

Lakeland Financial Reports Annual Net Income of $93.5 million, Organic Average Loan Growth of 5% and Average Deposit Growth of 4%

Written by Customer Service on January 24, 2025. Posted in Earnings Releases And Operating Results.

WARSAW, Ind., Jan. 24, 2025 (GLOBE NEWSWIRE) — Lakeland Financial Corporation (Nasdaq Global Select/LKFN), parent company of Lake City Bank, today reported net income of $93.5 million for the year ended December 31, 2024, versus $93.8 million for the year ended December 31, 2023. Diluted earnings per share were $3.63 for the twelve months ended December 31, 2024, versus $3.65 for 2023. Net income was $24.2 million for the three months ended December 31, 2024, a decrease of $5.4 million, or 18%, compared with net income of $29.6 million for the three months ended December 31, 2023. Diluted earnings per share of $0.94 for the fourth quarter of 2024 decreased by 19% from $1.16 for the fourth quarter of 2023. On a linked quarter basis, net income increased 4%, or $852,000, from third quarter 2024 net income of $23.3 million. Linked...

GXO Schedules Fourth Quarter, Full-Year 2024 Earnings Conference Call for Thursday, February 13, 2025

Written by Customer Service on January 24, 2025. Posted in Earnings Releases And Operating Results.

GREENWICH, Conn., Jan. 24, 2025 (GLOBE NEWSWIRE) — GXO Logistics, Inc. (NYSE: GXO) will hold its fourth quarter and full-year 2024 earnings conference call and webcast on Thursday, February 13, 2025, at 8:30 a.m. Eastern Time. The company’s results will be released after market close on Wednesday, February 12, 2025, and made available at that time on investors.gxo.com. Access information: Call toll-free from U.S./Canada: 877-407-8029 International callers: +1 201-689-8029 Conference ID: 13751179 Live webcast: investors.gxo.com A replay of the conference call will be available for approximately two weeks, until February 25, 2025, by calling toll-free (from U.S./Canada) 877-660-6853; international callers dial +1 201‑612‑7415. Use the passcode 13751179. About GXO Logistics GXO Logistics, Inc. (NYSE: GXO) is the world’s largest pure-play...

Month: January 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals